Today, Alcon (ACL), the maker of eye care products, has announced this morning that Novartis was buying the remaining 52% of Alcon that was held by Nestlé. What's odd is Novartis has offered 2.8 of its shares for ACL which works out $153, a lower price than the $164.35 Alcon closed at on Friday.
Our cost basis for Alcon is $159.51, and the stock is currently trading at $159.55.
We are selling shares immediately from the Top Stock Portfolio.
The Dynamic Growth weekly newsletter briefing will be posted later this morning. To access the "Weekly Briefing", go to the "Newsletter" link at the top of the page and sign in by establishing your own username and password.

